We are live on ! Find out more
PMD

Psychemedics Corporation

Delisted

PMD was delisted on the 12th of December, 2024.

52 hedge funds and large institutions have $44.5M invested in Psychemedics Corporation in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less funds holding

Funds holding: 5452 (-2)

10% less capital invested

Capital invested by funds: $49.4M → $44.5M (-$4.86M)

32% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 22

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
15
Reduced
22
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PAIM
26
Punch & Associates Investment Management
Minnesota
$239K +$30.9K +1,800 +12%
MC
27
Moors & Cabot
Massachusetts
$217K -$385K -22,407 -59%
CIS
28
Connors Investor Services
Pennsylvania
$216K +$43.4K +2,524 +20%
GI
29
GS Investments
Minnesota
$215K -$8.6K -500 -3%
MRCM
30
Mill Road Capital Management
Connecticut
$209K
AIM
31
Alambic Investment Management
California
$163K +$200K +11,636 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$156K -$2.82K -164 -1%
Wells Fargo
33
Wells Fargo
California
$133K +$70.2K +4,081 +75%
OSAM
34
O'Shaughnessy Asset Management
Connecticut
$75K -$6.19K -360 -6%
Morgan Stanley
35
Morgan Stanley
New York
$66K -$75.8K -4,412 -48%
PCM
36
Prelude Capital Management
New York
$53K +$30.1K +1,750 +86%
PAM
37
Panagora Asset Management
Massachusetts
$49K
Russell Investments Group
38
Russell Investments Group
United Kingdom
$29K +$3.01K +175 +9%
HIM
39
Hillsdale Investment Management
Ontario, Canada
$17K +$1.72K +100 +9%
JP Morgan Chase
40
JP Morgan Chase
New York
$14K -$171K -9,976 -91%
CCM
41
Copeland Capital Management
Pennsylvania
$11K +$963 +56 +8%
Deutsche Bank
42
Deutsche Bank
Germany
$9K -$7.01K -408 -37%
LFG
43
Larson Financial Group
Missouri
$6K
AG
44
Advisor Group
Arizona
$4K
TRCT
45
Tower Research Capital (TRC)
New York
$3K -$756 -44 -15%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$2K -$3.44K -200 -54%
Fidelity Investments
47
Fidelity Investments
Massachusetts
$2K -$1.58K -92 -38%
APA
48
American Portfolios Advisors
New York
$1.95K
Bank of America
49
Bank of America
North Carolina
$1K -$29K -1,688 -98%
DA
50
Denali Advisors
California
$1K

PMD Hedge Fund Activity: Q1 2019 in Review

52 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2019, worth a combined $44.5M — down 9.8% from $49.4M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PMD and 1 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 15 added.

The largest buyer was Kennedy Capital Management, adding an estimated $1.36M. The largest seller was LSV Asset Management, exiting entirely with an estimated $531K sold.

  • 52 institutional investors held Psychemedics Corporation (PMD) as of Q1 2019, down from 54 in Q4 2018.
  • Funds reported $44.5M of Psychemedics Corporation stock for Q1 2019, down 9.8% quarter-over-quarter.
  • 1 fund opened new Psychemedics Corporation positions in Q1 2019 and 3 closed out, a net change of -2 holders.
  • The largest Psychemedics Corporation buyer in Q1 2019 was Kennedy Capital Management, an estimated $1.36M added.
  • The largest Psychemedics Corporation seller in Q1 2019 was LSV Asset Management, an estimated $531K sold.

Based on aggregated 13F filings for Q1 2019.